MyDx EcoSmartPen
Significant resources have been deployed towards the development of the EcoSmartPen which is near completion and we expect to deploy on a limited basis as early as this summer. We are looking forward to rolling out the EcoSmartPen beginning here in California and growing throughout the country from there. Once again, each device used will only add to our ever growing database of user experience data. We have begun conversations with multiple nationwide Cannabis brands who are interested in partnering with MyDx and the EcoSmartPenTM to deploy within their existing sales channels. We look forward to completing these contracts and announcing the first of these once our pen has been completed and manufactured at a scale and is ready for deployment with our partners’ approval.

Revenues Expected to Increase in 2019
With these new revenue streams available in 2019 and the bulk of our R&D completed we expect to have significant improvement to both our revenue and bottom line in 2019. We expect deliveries to resume and sales to improve for the CannaDx in 2Q19 with new revenue streams from our MyDx360 Service and EcoSmartPen to follow.

In April 2018 the Company verbally agreed to enter into a separate MYDX360 SAAS Ecosystem License and Services Agreements with Q’NCH, LLC, a Delaware limited liability company and HotNife, LLC, a California limited liability company. (the “SAAS Agreements”). Under the terms of the SAAS Agreements, the Company granted the counterparties a non-exclusive limited license to: (i) access the Company’s Database (as defined in the SAAS Agreements) (the “Access License”), and (ii) use the Company’s “Powered by MyDx” trademark and the MyDx logo on the counterparties’ products (the “Brand License”, and together with the Access License, the “MyDx License”). Additionally, the SAAS Agreement provides the counterparties with (i) market research regarding the packaging of the counterparties’ products in coordination with the counterparties’ objectives (the “Brand Services”) and (ii) delivery of certain quantities of the Company’s smart devices, cartridges, batteries, and other hardware to the counterparties (the “Product Services” and, together with the Brand Services, the “MyDx Services”). The total consideration to the Company from each of the counterparties in exchange for the grant of the MyDx License and the MyDx Services will be $15,000 per year and the costs of the Eco Smart Pens’ hardware. The payments will not begin until the Company releases the Eco Smart Pen.

MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA

MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/

MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG

MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY,
https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html

How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of

'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.

SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.

MUCH.WATCH!MORE.CURRENT.MYDX.VIDEOS
Powered by MYDX, video now 531 views, from 3 views two weeks ago. Someones watching.

MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA

MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY,
https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html

MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.

It doesn't look to me that MYDX is going in the right direction to hit the TRIPS that I have been told so many times that was going to happen. LMAO, LMAO, LMAO. Is up 14 percent today the right direction? LOL

MYDX.GREEN.CLOSE.UP.14.PERCENT.TODAY.NEWS.COMING

MUCH.WATCH!MORE.CURRENT.MYDX.VIDEOS
Powered by MYDX, video now 528 views, from 3 views two weeks ago. Someones watching.

MYDX.10Q.LATE.and.UP.14.PERCENT.TODAY.LMAO

MYDX.GREEN.CLOSE.UP.14.PERCENT.TODAY Watch, the fake ask of 8 mil at 16 will be probably be 1 mil at 16 tomorrow morning. They know IT'S COMING and they cannot stop MYDX. MYDX FOR THE WIN! Shareholders ALL know what we have here.

Looks like MYDX is going in the wrong direction to hit the trips that I have been told so many times that I lost count, LOL.

THE FACTS: CLAIM against MYDX for NON-DELIVERY of PAID PRODUCT...

This is the exact lawsuit against MYDX that apparently a Francois Du Toit from South Africa is claiming to have filled. His direct statement on another site is 'I ordered several MyDx units for agency stock from MyDx. I guess it was FOTGOTTEN to mention claim is for MULTIPLE UNITS. I find it odd that the address given in the lawsuit filed with California Court for the Plaintiffs is CALIFORNIA, not South AFRICA. It's so convenient to forget to mention it's for MULTIPLE ANALYZERS.
Direct quote from Francois Du Toit: I will clarify. Ordered several analyser units end october 2018.

Buyer protection plan described below: The question to ask is why would someone not go back through PAYPAL, since that is how they are claiming the units were paid for, and get a refund since PAYPAL guarantees a refund if any problems, then to have to file a lawsuit against MYDX. Maybe they did try paypal refund and cannot get it because it is NOT warranted.

"Buyer protection ensures you get what you pay for. When something goes wrong with your eligible transactions, PayPal Buyer Protection has you covered. Get a full refund if an eligible order isn't significantly as described, or doesn't arrive at your doorstep."

This case is still ongoing and has not be decided to be factual by anyone.

GOTTA FEELING MYDX NEWS IS SOON!!

LMAO, MYDX UP 14.29 PERCENT RIGHT NOW!

Looks like some BUYERS before news is released.

TICK TOCK, MYDX ASK IS MOVING UP, NOW 16 - NEWS in the future.

I believe it's all part of MYDX's plan, Shareholders will all know the NEWS when the time is right. IT'S COMING.

MYDX could be waiting to release earnings under new company name if a merger/acquisition is in the works right now. NO WORRIES AT ALL.

10Q.UPDATE-'www.MYDX.LONGS.DONT.CARE.WHEN.IT.COMES.OUT.com'

MUCH.WATCH!MORE.CURRENT.MYDX.VIDEOS
Powered by MYDX, video now 524 views, from 3 views two weeks ago. Someones watching.

THE FACTS: CLAIM against MYDX for NON-DELIVERY of PAID PRODUCT...

This is the exact lawsuit against MYDX that apparently a Francois Du Toit from South Africa is claiming to have filled. His direct statement on another site is 'I ordered several MyDx units for agency stock from MyDx. I guess it was FOTGOTTEN to mention claim is for MULTIPLE UNITS. I find it odd that the address given in the lawsuit filed with California Court for the Plaintiffs is CALIFORNIA, not South AFRICA. It's so convenient to forget to mention it's for MULTIPLE ANALYZERS.
Direct quote from Francois Du Toit: I will clarify. Ordered several analyser units end october 2018.

Buyer protection plan described below: The question to ask is why would someone not go back through PAYPAL, since that is how they are claiming the units were paid for, and get a refund since PAYPAL guarantees a refund if any problems, then to have to file a lawsuit against MYDX. Maybe they did try paypal refund and cannot get it because it is NOT warranted.

"Buyer protection ensures you get what you pay for. When something goes wrong with your eligible transactions, PayPal Buyer Protection has you covered. Get a full refund if an eligible order isn't significantly as described, or doesn't arrive at your doorstep."

This case is still ongoing and has not be decided to be factual by anyone.

In April 2018 the Company verbally agreed to enter into a separate MYDX360 SAAS Ecosystem License and Services Agreements with Q’NCH, LLC, a Delaware limited liability company and HotNife, LLC, a California limited liability company. (the “SAAS Agreements”). Under the terms of the SAAS Agreements, the Company granted the counterparties a non-exclusive limited license to: (i) access the Company’s Database (as defined in the SAAS Agreements) (the “Access License”), and (ii) use the Company’s “Powered by MyDx” trademark and the MyDx logo on the counterparties’ products (the “Brand License”, and together with the Access License, the “MyDx License”). Additionally, the SAAS Agreement provides the counterparties with (i) market research regarding the packaging of the counterparties’ products in coordination with the counterparties’ objectives (the “Brand Services”) and (ii) delivery of certain quantities of the Company’s smart devices, cartridges, batteries, and other hardware to the counterparties (the “Product Services” and, together with the Brand Services, the “MyDx Services”). The total consideration to the Company from each of the counterparties in exchange for the grant of the MyDx License and the MyDx Services will be $15,000 per year and the costs of the Eco Smart Pens’ hardware. The payments will not begin until the Company releases the Eco Smart Pen.

MyDx EcoSmartPen
Significant resources have been deployed towards the development of the EcoSmartPen which is near completion and we expect to deploy on a limited basis as early as this summer. We are looking forward to rolling out the EcoSmartPen beginning here in California and growing throughout the country from there. Once again, each device used will only add to our ever growing database of user experience data. We have begun conversations with multiple nationwide Cannabis brands who are interested in partnering with MyDx and the EcoSmartPenTM to deploy within their existing sales channels. We look forward to completing these contracts and announcing the first of these once our pen has been completed and manufactured at a scale and is ready for deployment with our partners’ approval.

Revenues Expected to Increase in 2019
With these new revenue streams available in 2019 and the bulk of our R&D completed we expect to have significant improvement to both our revenue and bottom line in 2019. We expect deliveries to resume and sales to improve for the CannaDx in 2Q19 with new revenue streams from our MyDx360 Service and EcoSmartPen to follow.

MYDX: Involvement in Legal Proceedings

To the Company’s knowledge, none of our officers or our directors has, during the last ten years:


?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity

In January of 2018, MyDx’s Biopharmaceutical division commenced clinical trials on its unique MyDx360 Pain Management Formula, appointed Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran to its Executive Advisory Board on April 24, 2018, secured city and state legal cannabis manufacturing and distribution for its MyDx360 customers in May 2018, and featured the Eco Smart Pen working Prototype on CFN Media in August 2018. The MyDx Analyzer was selected to be used in a large HIV Study by the University of Florida in September 2018. MyDx recruited Mr. Cannabis Group to operate the Company in November 2018, onboarding a new experienced CFO/CEO (Mr. Matthew Bucciero), a leading Harvard neuroscientist (Just Vincent) to its scientific advisory board, and Mr. Erai Beckmann, a seasoned cannabis industry professional, as a member of the Board

As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has "not yet" been dismissed.

PORTABLE DEVICE AND METHOD FOR VAPORIZING MATERIALS
Publication number: 20190014824
Abstract: A portable device, and more particularly a portable device for vaporizing materials such as oils for inhalation. Also, methods for vaporizing materials and methods of operating portable vaporizing devices. In addition, networks for providing operational features and/or instructions for operation of vaporizing devices and for monitoring and collecting operational data. In preferred embodiments, a vaporizing device and/or methods for operating a vaporizing device wherein the vaporizing device includes one or more of the following features: security features to regulate operation of the device; automatic detection of vaporizing material identity; user experience monitoring and data collection; and/or temperature adjustment of vaporizing material based on detected material for vaporization.
Type: Application
Filed: November 21, 2017
Publication date: January 17, 2019
Inventors: Daniel Yazbeck, Joshua Londano, James Panther, Jason Panther

https://patents.justia.com/inventor/daniel-yazbeck?fbclid=IwAR3UrUz5kPH_YRaYvRl7rF_rrk79Xuj1viP3-YG0c8h60_GAtkKg_KnEII4

IT'S COMING: MYDX Eco Smart Pen app picture: https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG

MYDX VIDEO, 8,866 views, 3 negative comments out of EIGHT THOUSAND EIGHT HUNDRED SIXTY SIX VIEWS. WOW, Just more proof that MYDX is COMING! https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup

MYDX VIDEO: almost 34,540 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester

MYDX #4 on the Most Posted Cannabis Stocks Board, soon to hit number 1.

PER 10k dated 04/25/19 The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED"
Lawsuit Against Jerome Dewald and Skip Sanzeri

As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.